Rebus Holdings, Inc. (RBSH) financial statements (2022 and earlier)

Company profile

Business Address 2629 TOWNSGATE RD, SUITE 215
WESTLAKE VILLAGE, CA 91361
State of Incorp. DE
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments71140444105472,465
Cash and cash equivalents71140444105472,465
Restricted cash and investments  19327   
Prepaid expense4   5112114
Total current assets:71540423331156592,579
Noncurrent Assets
Property, plant and equipment  (7)24412
Intangible assets, net (including goodwill)  (229)33506884
Intangible assets, net (excluding goodwill)  (229)33506884
Other undisclosed noncurrent assets  236  33
Total noncurrent assets:   35547599
TOTAL ASSETS:71540423366697342,678
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities3,8054,2014,1353,8993,5071,6223,409
Accounts payable1,8012,2612,2692,0851,9681,238977
Accrued liabilities2,0041,9401,8661,8141,5393842,432
Debt2501,8782,8262,6002,476  
Derivative instruments and hedges, liabilities1,1246,8281,7852,1342,9342,5411,177
Other undisclosed current liabilities448      
Total current liabilities:5,62712,9078,7468,6338,9174,1634,586
Noncurrent Liabilities
Long-term debt and lease obligation20      
Long-term debt, excluding current maturities20      
Other undisclosed noncurrent liabilities90      
Total noncurrent liabilities:110      
Total liabilities:5,73712,9078,7468,6338,9174,1634,586
Stockholders' equity
Stockholders' equity attributable to parent(5,022)(12,503)(8,723)(8,267)(8,848)(3,429)(1,908)
Common stock119281 4
Additional paid in capital59,25454,45351,95551,47150,88545,39143,353
Accumulated deficit(64,277)(66,975)(60,680)(59,746)(59,734)(48,820)(45,265)
Total stockholders' equity:(5,022)(12,503)(8,723)(8,267)(8,848)(3,429)(1,908)
TOTAL LIABILITIES AND EQUITY:71540423366697342,678

Income statement (P&L) ($ in thousands)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
Operating expenses(1,022)(2,481)(609)(724)(5,851)(3,190)(6,067)
Operating loss:(1,022)(2,481)(609)(724)(5,851)(3,190)(6,067)
Interest and debt expense1,11633412521088  
Other undisclosed income (loss) from continuing operations before equity method investments, income taxes2,604(4,148)(450)502(5,337)(365)181
Net income (loss) attributable to parent:2,698(6,295)(934)(12)(11,100)(3,555)(5,886)
Preferred stock dividends and other adjustments 6454(196)(2,204)  
Other undisclosed net loss available to common stockholders, basic (128)(108)    
Net income (loss) available to common stockholders, basic:2,698(6,359)(988)(208)(13,304)(3,555)(5,886)
Other undisclosed net loss available to common stockholders, diluted(4,099)      
Net loss available to common stockholders, diluted:(1,401)(6,359)(988)(208)(13,304)(3,555)(5,886)

Comprehensive Income ($ in thousands)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
Net income (loss):2,698(6,295)(934)(12)(11,100)(3,555)(5,886)
Comprehensive income (loss), net of tax, attributable to parent:2,698(6,295)(934)(12)(11,100)(3,555)(5,886)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: